1. Clinical staging in pancreatic adenocarcinoma underestimates extent of disease. (March 2019) Authors: Chawla, A.; Ferrone, C.R.; Lillemoe, K.D.; Ryan, D.P.; Hong, T.S.; Blaszkowsky, L.S.; Fernandez del Castillo, C.; Qadan, M. Journal: HPB Issue: Volume 21(2019)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Counterclockwise maxillomandibular advancement surgery and disc repositioning: can condylar remodeling in the long-term follow-up be predicted?. Issue 12 (December 2017) Authors: Gomes, L.R.; Cevidanes, L.H.; Gomes, M.R.; Ruellas, A.C.; Ryan, D.P.; Paniagua, B.; Wolford, L.M.; Gonçalves, J.R. Journal: International journal of oral & maxillofacial surgery Issue: Volume 46:Issue 12(2017:Dec.) Page Start: 1569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Enhancement of anti-tumor immunity and survival prolongation by neoadjuvant 5-FU, oxaliplatin and irinotecan (folfirinox) in pancreatic ductal adenocarcinoma patients. (March 2018) Authors: Cai, L.; Michelakos, T.; Castillo, C.F.; Yamada, T.; Taylor, M.S.; Deshpande, V.; Qadan, M.; Allen, J.; Clark, J.W.; Hong, T.S.; Ryan, D.P.; Wo, J.Y.; Warshaw, A.L.; Lillemoe, K.D.; Ferrone, S.; Ferrone, C.R. Journal: HPB Issue: Volume 20(2018)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗